Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 2
1983 1
1984 3
1991 1
1992 1
1993 2
1994 1
1996 1
1998 1
2002 3
2003 1
2004 2
2005 2
2006 5
2007 16
2008 8
2009 11
2010 14
2011 19
2012 13
2013 16
2014 18
2015 13
2016 6
2017 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

141 results

Results by year

Filters applied: . Clear all
Page 1
Pharmacogenetics of antiretroviral therapy.
Barreiro P, Fernández-Montero JV, de Mendoza C, Labarga P, Soriano V. Barreiro P, et al. Among authors: labarga p. Expert Opin Drug Metab Toxicol. 2014 Aug;10(8):1119-30. doi: 10.1517/17425255.2014.930128. Epub 2014 Jun 18. Expert Opin Drug Metab Toxicol. 2014. PMID: 24941049 Review.
Dual antiretroviral therapy for HIV infection.
Soriano V, Fernandez-Montero JV, Benitez-Gutierrez L, Mendoza C, Arias A, Barreiro P, Peña JM, Labarga P. Soriano V, et al. Among authors: labarga p. Expert Opin Drug Saf. 2017 Aug;16(8):923-932. doi: 10.1080/14740338.2017.1343300. Epub 2017 Jul 11. Expert Opin Drug Saf. 2017. PMID: 28621159 Review.
Update on HIV/HCV coinfection.
Soriano V, Vispo E, Fernandez-Montero JV, Labarga P, Barreiro P. Soriano V, et al. Among authors: labarga p. Curr HIV/AIDS Rep. 2013 Sep;10(3):226-34. doi: 10.1007/s11904-013-0169-5. Curr HIV/AIDS Rep. 2013. PMID: 23832718 Review.
Pharmacogenetics of tenofovir treatment.
Rodriguez-Novoa S, Labarga P, Soriano V. Rodriguez-Novoa S, et al. Among authors: labarga p. Pharmacogenomics. 2009 Oct;10(10):1675-85. doi: 10.2217/pgs.09.115. Pharmacogenomics. 2009. PMID: 19842939 Review.
Hepatitis C cure with antiviral therapy--benefits beyond the liver.
Soriano V, Labarga P, Fernandez-Montero JV, de Mendoza C, Esposito I, Benítez-Gutiérrez L, Barreiro P. Soriano V, et al. Among authors: labarga p. Antivir Ther. 2016;21(1):1-8. doi: 10.3851/IMP2975. Epub 2015 Jun 25. Antivir Ther. 2016. PMID: 26110692 Review.
Renal toxicity associated with tenofovir use.
Rodriguez-Nóvoa S, Alvarez E, Labarga P, Soriano V. Rodriguez-Nóvoa S, et al. Among authors: labarga p. Expert Opin Drug Saf. 2010 Jul;9(4):545-59. doi: 10.1517/14740331003627458. Expert Opin Drug Saf. 2010. PMID: 20384533 Review.
Dolutegravir, abacavir and lamivudine as HIV therapy.
Fernandez-Montero JV, Barreiro P, Labarga P, De Mendoza C, Soriano V. Fernandez-Montero JV, et al. Among authors: labarga p. Expert Opin Pharmacother. 2014 May;15(7):1051-7. doi: 10.1517/14656566.2014.913023. Expert Opin Pharmacother. 2014. PMID: 24754315 Review.
Directly acting antivirals against hepatitis C virus.
Soriano V, Vispo E, Poveda E, Labarga P, Martin-Carbonero L, Fernandez-Montero JV, Barreiro P. Soriano V, et al. Among authors: labarga p. J Antimicrob Chemother. 2011 Aug;66(8):1673-86. doi: 10.1093/jac/dkr215. Epub 2011 Jun 7. J Antimicrob Chemother. 2011. PMID: 21652618 Review.
141 results